Locations
St. Louis, MO, USA · North America
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2015
Geneoscopy is a pioneering company focused on transforming gastrointestinal health through innovative, noninvasive diagnostic tests. Their primary product, a stool-based colorectal cancer screening test, utilizes advanced molecular technologies to improve disease detection, treatment, and monitoring. By addressing the barriers associated with traditional colonoscopy, Geneoscopy aims to enhance patient access to screening and improve health equity. The company has made significant strides in the market, including FDA approval for its Colo Sense™ test and partnerships with major laboratories, positioning itself as a leader in gastrointestinal diagnostics.
Something looks off?On-site & Remote